rVSV-ZEBOV vaccine

The rVSV-ZEBOV vaccine is designed to protect against Ebola virus disease. It uses a harmless virus, called a vesicular stomatitis virus, modified to carry Ebola virus proteins. When injected, it stimulates the immune system to recognize and fight Ebola without causing the disease. This vaccine has shown high effectiveness in preventing Ebola outbreaks and is used in emergency responses and vaccination campaigns in affected regions, helping to control the spread of the virus and protect at-risk populations.